Research Article
Efficacy of Transarterial Chemoembolisation with or without Antiviral Therapy for Patients with Hepatocellular Carcinoma after Radical Hepatectomy
Table 1
Preoperative demographic characteristics of patients in the three groups.
| | Preoperative patient demographic | Control group | TACE group | Combined group | value |
| | Gender | Male | 31 (77.5%) | 26 (65%) | 32 (80.0%) | 0.263 | | Female | 9 (22.5%) | 14 (35%) | 8 (20.0%) | | Age (y) | | 52.25 ± 8.42 | 51.58 ± 8.26 | 49.78 ± 9.51 | 0.427 | | Ascites | Medically controlled | 19 (47.5%) | 5 (12.5%) | 0 (0.0%) | 0.000 | | No | 21 (52.5%) | 35 (87.5%) | 40 (100.0%) | | Hepatic encephalopathy | Yes | 0 (0.0%) | 0 (0.0%) | 0 (0.0%) | 1.000 | | No | 40 (100.0%) | 40 (100.0%) | 40 (100.0%) | | INR | | 1.06 ± 0.81 | 1.05 ± 0.75 | 1.06 ± 0.78 | 0.947 | | Total bilirubin (μmol/L) | | 18.88 ± 4.29 | 19.53 ± 3.74 | 18.96 ± 4.14 | 0.739 | | Total serum protein (g/L) | | 35.93 ± 3.72 | 34.30 ± 1.96 | 35.80 ± 2.97 | 0.028 | | Child–Pugh class | A | 33 (82.5%) | 35 (87.5%) | 36 (90.0%) | 0.606 | | B | 7 (17.5%) | 5 (12.5%) | 4 (10.0%) | | ALT (U/L) | | 44.68 ± 9.96 | 50.00 ± 9.83 | 47.95 ± 12.48 | 0.090 | | ALP (U/L) | | 151.98 ± 70.39 | 149.10 ± 91.02 | 127.40 ± 70.52 | 0.308 | | AST (U/L) | | 40.70 ± 8.41 | 44.58 ± 10.11 | 43.08 ± 11.07 | 0.217 | | Cr (μmol/L) | | 62.48 ± 13.06 | 60.93 ± 11.87 | 62.38 ± 12.32 | 0.823 | | WBC (×109/L) | | 4.69 ± 0.57 | 4.88 ± 0.80 | 4.93 ± 7.95 | 0.304 | | RBC (×1012/L) | | 3.47 ± 0.36 | 3.32 ± 0.27 | 3.34 ± 0.33 | 0.100 | | PLT (×109/L) | | 88.58 ± 19.61 | 90.48 ± 18.63 | 87.73 ± 23.37 | 0.830 | | Hb (g/L) | | 118.30 ± 18.89 | 113.48 ± 14.56 | 116.05 ± 14.16 | 0.406 | | AFP (ng/mL) | | 474.10 ± 185.44 | 949.80 ± 1160.62 | 710.76 ± 906.18 | 0.052 | | CEA (ng/mL) | | 2.15 ± 0.48 | 2.09 ± 0.52 | 2.24 ± 0.77 | 0.534 | | CA199 (ng/mL) | | 22.35 ± 4.43 | 20.80 ± 4.38 | 19.96 ± 4.66 | 0.058 | | HbsAg | Positive | 40 (100.0%) | 40 (100.0%) | 40 (100.0%) | 1.000 | | Negative | 0 (0.0%) | 0 (0.0%) | 0 (0.0%) | | HbsAb | Positive | 7 (17.5%) | 17 (42.5%) | 16 (40.0%) | 0.034 | | Negative | 33 (82.5%) | 23 (57.5%) | 24 (60.0%) | | HbcAb | Positive | 40 (100.0%) | 40 (100.0%) | 40 (100.0%) | 1.000 | | Negative | 0 (0.0%) | 0 (0.0%) | 0 (0.0%) | | HbeAg | Positive | 40 (100.0%) | 40 (100.0%) | 40 (100.0%) | 1.000 | | Negative | 0 (0.0%) | 0 (0.0%) | 0 (0.0%) | | HbeAb | Positive | 40 (100.0%) | 0 (0.0%) | 0 (0.0%) | 1.000 | | Negative | 0 (0.0%) | 40 (100.0%) | 40 (100.0%) | | HBA DNA level | | 2.93 × 105 | 1.16 × 106 | 5.66 × 105 | 0.501 |
|
|
